JAMA : the journal of the American Medical Association
The most recent articles from:
JAMA
-
Review Case Reports
Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes.
There is substantial uncertainty about optimal glycemic control in older adults with type 2 diabetes mellitus. ⋯ High-quality evidence about glycemic treatment in older adults is lacking. Optimal decisions need to be made collaboratively with patients, incorporating the likelihood of benefits and harms and patient preferences about treatment and treatment burden. For the majority of older adults, an HbA1c target between 7.5% and 9% will maximize benefits and minimize harms.